- Home
- ZUMZ vs PEPG Comparison
ZUMZ vs PEPG Comparison
Compare ZUMZ & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- PEPG
- Stock Information
- Founded
- ZUMZ 1978
- PEPG 2018
- Country
- ZUMZ United States
- PEPG United States
- Employees
- ZUMZ N/A
- PEPG N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- ZUMZ Consumer Discretionary
- PEPG Health Care
- Exchange
- ZUMZ Nasdaq
- PEPG Nasdaq
- Market Cap
- ZUMZ 363.1M
- PEPG 317.6M
- IPO Year
- ZUMZ 2005
- PEPG 2022
- Fundamental
- Price
- ZUMZ $23.29
- PEPG $4.97
- Analyst Decision
- ZUMZ Hold
- PEPG Strong Buy
- Analyst Count
- ZUMZ 1
- PEPG 6
- Target Price
- ZUMZ $18.00
- PEPG $9.17
- AVG Volume (30 Days)
- ZUMZ 188.1K
- PEPG 676.6K
- Earning Date
- ZUMZ 12-04-2025
- PEPG 11-06-2025
- Dividend Yield
- ZUMZ N/A
- PEPG N/A
- EPS Growth
- ZUMZ N/A
- PEPG N/A
- EPS
- ZUMZ 0.03
- PEPG N/A
- Revenue
- ZUMZ $900,253,000.00
- PEPG N/A
- Revenue This Year
- ZUMZ $5.50
- PEPG N/A
- Revenue Next Year
- ZUMZ $1.36
- PEPG N/A
- P/E Ratio
- ZUMZ $663.11
- PEPG N/A
- Revenue Growth
- ZUMZ 1.64
- PEPG N/A
- 52 Week Low
- ZUMZ $11.31
- PEPG $0.88
- 52 Week High
- ZUMZ $24.37
- PEPG $6.85
- Technical
- Relative Strength Index (RSI)
- ZUMZ 65.97
- PEPG 58.68
- Support Level
- ZUMZ $21.27
- PEPG $4.05
- Resistance Level
- ZUMZ $22.49
- PEPG $4.89
- Average True Range (ATR)
- ZUMZ 0.86
- PEPG 0.41
- MACD
- ZUMZ 0.02
- PEPG -0.06
- Stochastic Oscillator
- ZUMZ 86.69
- PEPG 61.91
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.